NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-117-2011-0-CR-26 Recombinant Immunotoxin Targeting Mesothelin CR National Stage 2013-0571 Abandoned
NCI E-117-2011-0-CO-25 Recombinant Immunotoxin Targeting Mesothelin CO National Stage 13-274.153 Abandoned
NCI E-117-2011-0-EC-07 Recombinant Immunotoxin Targeting Mesothelin EC National Stage SP-13-13067 Abandoned
NCI E-117-2011-0-VN-20 Recombinant Immunotoxin Targeting Mesothelin VN National Stage 1-2013-03855 Abandoned
NCATS E-072-2012-0-US-01 Modulators Of The Relaxin Receptor 1 US 61/642,986 Abandoned
NCI E-077-2012-0-US-01 Use Of CPG Oligonucleotides To Inhibit Chemotherapy Induced Pneumonitis US 61/643,088 Abandoned
NCI E-117-2011-0-BR-04 Recombinant Immunotoxin Targeting Mesothelin BR National Stage 112013028537-0 Abandoned
NCI E-117-2011-0-DZ-31 Recombinant Immunotoxin Targeting Mesothelin DZ National Stage 2058-07-13 Abandoned
NIDA E-233-2012-0-US-01 HETEROCYCLE-FUSED MORPHINANS, USE THEREOF AND PREPARATION THEREOF US 61/641,355 Abandoned
CC E-198-2011-0-US-01 Imaging Thermometry US 61/641,315 Abandoned
NIAID E-575-2013-1-US-01 VACCINE FOR FALCIPARUM MALARIA US 61/641,445 Abandoned
NINDS E-225-2009-0-US-03 Composition and Methods for the Treatment or Prevention of Mitochondrial Diseases US National Stage 13/460,852 Abandoned
NCI E-074-2007-0-US-10 Brachyury Polypeptides And Methods For Use US CON 13/460,587 8613933 Issued PDF
CC E-126-2011-0-PCT-02 CHEMICAL MODIFICATION OF APOLIPOPROTEIN MIMETIC PEPTIDES FOR THE PRODUCTION OF THERAPEUTIC AGENTS PCT PCT PCT/ US12/35870 Expired
CC E-126-2011-0-EP-05 CHEMICAL MODIFICATION OF APOLIPOPROTEIN MIMETIC PEPTIDES FOR THE PRODUCTION OF THERAPEUTIC AGENTS EP National Stage 12726266.5 Abandoned
CC E-126-2011-0-AU-03 CHEMICAL MODIFICATION OF APOLIPOPROTEIN MIMETIC PEPTIDES FOR THE PRODUCTION OF THERAPEUTIC AGENTS AU National Stage 2012249301 Abandoned
CC E-126-2011-0-CA-04 CHEMICAL MODIFICATION OF APOLIPOPROTEIN MIMETIC PEPTIDES FOR THE PRODUCTION OF THERAPEUTIC AGENTS CA National Stage 2834657 Abandoned
NIDCR E-233-2000-0-JP-09 Adult Human Dental Pulp Stem Cells In Vitro and In Vivo JP DIV 2012-103397 Expired
NCI E-294-2011-0-US-01 Use Of CpG Oligonucleotides Co-formulated With An Antibiotic To Accelerate Wound Healing US 61/639,688 Abandoned
NCI E-230-2011-0-US-01 Vascular Endothelial Growth Factor Antagonists And Methods For Their Use US 61/639,230 Abandoned
NCI E-181-2006-0-ES-19 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer ES EP 12165734.0 Abandoned
NCI E-181-2006-0-IT-21 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer IT EP 12165734.0 Abandoned
NCI E-181-2006-0-FR-20 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer FR EP 12165734.0 Abandoned
NCI E-181-2006-0-ES-16 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer ES EP 12165748.0 Abandoned
NIAID E-071-2012-0-US-01 BISPECIFIC ANTIBODIES TO TREAT HIV-1 INFECTION US 61/638,437 Abandoned
NEI E-036-2012-0-US-01 Methods of Producing And Using Regulatory B Cells US 61/637,915 Abandoned
NIA E-158-2012-1-US-01 Use Of Erythropoietin And Derivatives For Treating Hypertension US 61/638,328 Abandoned
NCI E-039-2003-0-US-04 Individualized Therapy Using Interdependent Protein Signal Network US CON 13/455,111 8835360 Expired PDF
NCATS E-094-2011-0-PCT-02 Inhibitors Of Human Apurinic/Apyrimidinic Endonuclease 1 PCT PCT PCT/US12/34755 Abandoned
NCI E-132-2010-0-US-03 Methods Of Diagnosing And Prognosing Colonic Polyps US National Stage 13/504,154 Abandoned
NCI E-144-2011-0-PCT-02 Transient Hypoxia Inducers And Their Use PCT PCT PCT/US2012/034534 Expired
NIA E-158-2012-0-US-01 Use of Erythropoietin And Derivatives For Treating Hypertension US 61/636,547 Abandoned
NCI E-130-2011-0-CN-13 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof CN DIV 201610290837.3 Issued
NCI E-130-2011-0-HK-11 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof HK National Stage 16108042.3 Issued
NCI E-130-2011-0-EP-07 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof EP DIV 15188264.4 Issued
NCI E-130-2011-0-EP-14 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof EP DIV 16166924.7 Issued
NCI E-130-2011-0-ES-17 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof ES EP 16166924.7 Issued
NCI E-130-2011-0-DE-16 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof DE EP 16166924.7 Issued
NCI E-130-2011-0-FR-18 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof FR EP 16166924.7 Issued
NCI E-130-2011-0-IT-20 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof IT EP 16166924.7 Issued
NCI E-130-2011-0-GB-19 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof GB EP 16166924.7 Issued
NIDCR E-142-2011-0-EP-04 AAV Mediated Exendin-4 Gene Transfer to Salivary Glands to Protect Subjects From Diabetes or Obesity EP National Stage 12773975.3 Issued
NIAID E-283-2009-1-US-06 Compounds That Treat Malaria And Prevent Malaria Transmission US National Stage 13/392,668 9375424 Issued PDF
NCI E-130-2011-0-CN-03 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof CN National Stage 201280029201.3 Issued
NCI E-130-2011-0-GB-10 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof GB EP 12717009.0 Issued
NCI E-130-2011-0-FR-09 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof FR EP 12717009.0 Issued
NCI E-130-2011-0-DE-08 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof DE EP 12717009.0 Issued
NCI E-130-2011-0-EP-04 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof EP National Stage 12717009.0 Issued
NIDCR E-142-2011-0-PCT-02 AAV Mediated Exendin-4 Gene Transfer to Salivary Glands to Protect Subject From Diabetes or Obesity PCT PCT PCT/US12/34268 Expired
NCI E-130-2011-0-PCT-02 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof PCT PCT PCT/US2012/034186 Expired